Cornell University

Rakhi Naik

Shahin Rafii

Vivek Mittal

Linda Vahdat

Maureen Lane

Methods of determining cancer progression or cancer relapse in a subject at risk for cancer progression or cancer relapse, the methods comprising: obtaining a sample from said subject; measuring the level of VEGFR1hematopoietic progenitor cells (HPCs) and/or VEGFR2endothelial progenitor cells (EPCs) in said sample; and taking additional samples and conducting additional measurements of HPCs and/or EPCs at one or more later time points. From the measurements, it can be determined whether there is a surge in the level of HPCs and/or EPCs in at least one later measurement, relative to an earlier measurement. A surge in the level of HPCs and/or EPCs indicates increased risk of progression or relapse of said subject's cancer.

Growing community of inventors

Columbia, MD, United States of America

Rakhi Naik